ProShares UltraPro Short QQQ, CoreWeave, Inc. Class A Common Stock, and Intra-Cellular Therapies are the three Value stocks to watch today, according to MarketBeat's stock screener tool. Value stocks are shares of companies that appear to be trading for less than their intrinsic value based on fundamental analysis, such as low price-to-earnings or price-to-book ratios. Investors in value stocks typically anticipate that the market will eventually recognize the company's true worth, leading to price appreciation over time. These companies had the highest dollar trading volume of any Value stocks within the last several days.
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
Shares of NASDAQ:SQQQ traded down $0.53 during mid-day trading on Wednesday, hitting $36.91. 86,376,573 shares of the company traded hands, compared to its average volume of 41,649,692. ProShares UltraPro Short QQQ has a 12-month low of $26.21 and a 12-month high of $64.95. The stock has a 50-day moving average price of $31.91 and a two-hundred day moving average price of $32.93.
Read Our Latest Research Report on SQQQ
CoreWeave, Inc. Class A Common Stock (CRWV)
CoreWeave powers the creation and delivery of the intelligence that drives innovation. We are the AI Hyperscaler™ driving the AI revolution(1). Our CoreWeave Cloud Platform consists of our proprietary software and cloud services that deliver the software and software intelligence needed to manage complex AI infrastructure at scale.
NASDAQ CRWV traded up $2.09 on Wednesday, hitting $54.66. The stock had a trading volume of 40,251,100 shares, compared to its average volume of 30,987,895. CoreWeave, Inc. Class A Common Stock has a 52-week low of $36.00 and a 52-week high of $64.62.
Read Our Latest Research Report on CRWV
Intra-Cellular Therapies (ITCI)
Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that address medical needs primarily in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms in the central nervous system (CNS) in the United States.
ITCI stock traded down $0.01 during midday trading on Wednesday, hitting $131.91. The stock had a trading volume of 16,042,154 shares, compared to its average volume of 1,460,295. Intra-Cellular Therapies has a 52-week low of $64.09 and a 52-week high of $131.98. The business has a 50-day moving average of $129.34 and a two-hundred day moving average of $100.60. The firm has a market cap of $14.05 billion, a price-to-earnings ratio of -151.62 and a beta of 0.69.
Read Our Latest Research Report on ITCI
Recommended Stories
Before you consider ProShares UltraPro Short QQQ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProShares UltraPro Short QQQ wasn't on the list.
While ProShares UltraPro Short QQQ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
